Federal and Regulatory Outreach

AMRPA Submits Comments on CY 2021 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule

October 6, 2020
Physician Fee Schedule Regulatory Telehealth

AMRPA Letter to Congressional Leadership Regarding IMPACT Act’s Timeline & Prototype Testing

July 30, 2020
IMPACT Act IRF QRP Legislative Quality

AMRPA’s Response to the CMS Proposed Rule on Inpatient Prospective Payment System for FY 2021

July 10, 2020
IPPS/LTCH PPS Price Transparency Regulatory

AMRPA’s Submissions to the CMS Interim Final Rule on COVID-19

July 9, 2020
Burden Reduction COVID-19 Price Transparency Prior Authorization Regulatory Telehealth

AMRPA Recommendations to Senate HELP Committee Regarding Pandemic Preparedness Legislation

June 26, 2020
COVID-19 Legislative Prior Authorization Telehealth

AMRPA Submits Comments on Fiscal Year 2021 Inpatient Rehabilitation Facility Prospective Payment System Proposed Rule

June 5, 2020
Burden Reduction IRF PPS IRF QRP Regulatory

AMRPA Response to Medicare Advantage Part C Proposed Rule for FY 2021 and 2022

April 6, 2020
Medicare Advantage Prior Authorization

Letter to HHS & CMS Administrators Regarding COVID-19

March 13, 2020
COVID-19

AMRPA Response to U.S. News Proposed 2020-2021 Rehabilitation Hospital Ranking Methodology

March 10, 2020
Rehab Rankings

AMRPA Responds to CMS: Advance Notice of Methodological Changes for Calendar Year (CY) 2021 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies – Part II

March 6, 2020
Medicare Advantage Prior Authorization Regulatory

AMRPA Statement on Fiscal Year 2021 HHS Budget Proposal

February 25, 2020
Burden Reduction Medicare Advantage Prior Authorization

AMRPA Responds to Proposed Rules on Anti-Kickback Statute and Physician Self-Referral Regulations

December 31, 2019
Regulatory
Scroll to Top
Skip to content